First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.

Autor: Stephenson, Kathryn E.1,2,3, Keefer, Michael C.4, Bunce, Catherine A.4, Frances, Doreen4, Abbink, Peter1, Maxfield, Lori F.1, Neubauer, George H.1, Nkolola, Joseph1, Peter, Lauren1, Lane, Christopher4, Park, Harriet5, Verlinde, Carl5, Lombardo, Angela5, Yallop, Christopher6, Havenga, Menzo6, Fast, Patricia5, Treanor, John4, Barouch, Dan H.1,2,3 dbarouch@bidmc.harvard.edu
Zdroj: PLoS ONE. 11/14/2018, Vol. 13 Issue 11, p1-13. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje